These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 31101704)
21. Pharmaceutical vials with extremely high chemical inertness. Walther M; Rupertus V; Seemann C; Brecht J; Hormes R; Swift RW PDA J Pharm Sci Technol; 2002; 56(3):124-9. PubMed ID: 12109332 [TBL] [Abstract][Full Text] [Related]
22. Investigating the Effects of the Chemical Composition on Glass Corrosion: A Case Study for Type I Vials. Panighello S; Pinato O PDA J Pharm Sci Technol; 2020; 74(2):185-200. PubMed ID: 31615925 [TBL] [Abstract][Full Text] [Related]
23. Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part II: amino acids for parenteral nutrition. Bohrer D; do Nascimento PC; Binotto R; Carlesso R J Trace Elem Med Biol; 2001; 15(2-3):103-8. PubMed ID: 11787973 [TBL] [Abstract][Full Text] [Related]
24. Fill volume as an indicator of surface heterogeneity in glass vials for parenteral packaging. Kucko NW; Keenan T; Coughlan A; Hall MM J Pharm Sci; 2013 Jun; 102(6):1690-1695. PubMed ID: 23558423 [TBL] [Abstract][Full Text] [Related]
25. Introducing the Alba Chillon A; Pace A; Zuccato D PDA J Pharm Sci Technol; 2018; 72(4):382-392. PubMed ID: 29853611 [TBL] [Abstract][Full Text] [Related]
32. Effects of phosphate buffer in parenteral drugs on particle formation from glass vials. Ogawa T; Miyajima M; Wakiyama N; Terada K Chem Pharm Bull (Tokyo); 2013; 61(5):539-45. PubMed ID: 23420583 [TBL] [Abstract][Full Text] [Related]
33. A case study of nondelamination glass dissolution resulting in visible particles: implications for neutral pH formulations. Ratnaswamy G; Hair A; Li G; Thirumangalathu R; Nashed-Samuel Y; Brych L; Dharmavaram V; Wen ZQ; Fujimori K; Jing W; Sethuraman A; Swift R; Ricci MS; Piedmonte DM J Pharm Sci; 2014 Apr; 103(4):1104-14. PubMed ID: 24496956 [TBL] [Abstract][Full Text] [Related]
34. There Is Still Room for Improvement: Presentation of a Neutral Borosilicate Glass with Improved Chemical Stability for Parenteral Packaging. Boltres B; Tratzky S; Kass C; Eichholz R; Naß P PDA J Pharm Sci Technol; 2016; 70(4):346-52. PubMed ID: 27091891 [TBL] [Abstract][Full Text] [Related]
35. Quality attributes and evaluation of pharmaceutical glass containers for parenterals. Srinivasan C; Ma Y; Liu Y; Wang Y; Hengst L; Liu X; Toth R; Rodriguez J; Mohammad A; Bandaranayake BMB; Simon D; Beekman C; Korang-Yeboah M; Sivan S; Lee SL; Cruz CN Int J Pharm; 2019 Sep; 568():118510. PubMed ID: 31302170 [TBL] [Abstract][Full Text] [Related]
36. Characterization of surface properties of glass vials used as primary packaging material for parenterals. Ditter D; Mahler HC; Roehl H; Wahl M; Huwyler J; Nieto A; Allmendinger A Eur J Pharm Biopharm; 2018 Apr; 125():58-67. PubMed ID: 29331438 [TBL] [Abstract][Full Text] [Related]
37. Impact of Vial Washing and Depyrogenation on Surface Properties and Delamination Risk of Glass Vials. Ditter D; Mahler HC; Gohlke L; Nieto A; Roehl H; Huwyler J; Wahl M; Allmendinger A Pharm Res; 2018 May; 35(7):146. PubMed ID: 29796727 [TBL] [Abstract][Full Text] [Related]
38. Enhancing Patient Safety through the Use of a Pharmaceutical Glass Designed To Prevent Cracked Containers. Schaut RA; Hoff KC; Demartino SE; Denson WK; Verkleeren RL PDA J Pharm Sci Technol; 2017; 71(6):511-528. PubMed ID: 28928290 [TBL] [Abstract][Full Text] [Related]
39. Inhibiting Sterilization-Induced Oxidation of Large Molecule Therapeutics Packaged in Plastic Parenteral Vials. Vieregg JR; Martin SJ; Breeland AP; Weikart CM; Tirrell MV PDA J Pharm Sci Technol; 2018; 72(1):35-43. PubMed ID: 28928291 [TBL] [Abstract][Full Text] [Related]